 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News GlaxoSmithKline Allows Kenyan Firm to Make Cheap AIDS DrugsSeptember 22, 2004 On Wednesday in Nairobi, pharmaceutical maker GlaxoSmithKline (GSK) signed an agreement with Cosmos Limited that allows the Kenyan firm to make generics containing zidovudine and lamivudine and market the drugs in East Africa, including in Kenya, Rwanda and Burundi. Cosmos will begin manufacturing the drugs "in the next couple of weeks," said Prakash Patel, the firm's managing director. Patel said the drugs' costs would depend on the level of production. "We are pleased that another local health-care company will play a significant role in addressing the HIV/AIDS crisis," said Andrew Bullock, GSK's general manager for East Africa. Agence France Presse 09.22.04  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
